Literature DB >> 26187094

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.

Jian-Qiang Lu1, Benjamin Adam, Andrew S Jack, Anna Lam, Robert W Broad, Constance L Chik.   

Abstract

Tumor immune microenvironment has been gradually recognized as a key contributor to tumor development, progression, and control. Immune cell infiltrates in brain tumors have been increasingly studied, but few have published on immune cell infiltrates in pituitary adenomas. We quantitatively assessed the infiltration of macrophages and lymphocytes in 35 pituitary adenomas, including 9 densely granulated growth hormone (DG-GH), 9 sparsely granulated growth hormone (SG-GH), 9 null cell (NC), and 8 adrenocorticotropic hormone (ACTH) adenomas. All the adenomas showed varying degrees of CD68+ macrophage infiltration. While SG-GH adenomas were significantly larger in size than DG-GH and ACTH adenomas, the infiltration of CD68+ macrophages was significantly greater in SG-GH than in DG-GH and ACTH adenomas. Similarly, NC adenomas that were significantly larger than DG-GH and ACTH adenomas had significantly greater infiltration of CD68+ macrophages than DG-GH and ACTH adenomas. The numbers of CD68+ macrophages were positively correlated with the tumor sizes and Knosp classification grades for tumor invasiveness. The infiltration of CD4+ and CD8+ T cells was relatively scant in these adenomas, but GH adenomas exhibited significantly more CD4+ and CD8+ T cells than non-GH adenomas. Both DG-GH and SG-GH adenomas had significantly more CD4+ cells than ACTH adenomas and significantly more CD8+ cells than NC adenomas. These results suggest an association of CD68+ macrophage infiltration with an increase in the pituitary adenoma size and invasiveness. Our observation contributes to understanding the growth environment of pituitary adenomas, for which adjuvant immunotherapy may help to constrain the tumor enlargement and invasiveness.

Entities:  

Mesh:

Year:  2015        PMID: 26187094     DOI: 10.1007/s12022-015-9383-6

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  38 in total

1.  Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection.

Authors:  Bo Wang; Dazhi Xu; Xingjuan Yu; Tong Ding; Huilan Rao; Youqing Zhan; Limin Zheng; Lian Li
Journal:  Ann Surg Oncol       Date:  2011-02-23       Impact factor: 5.344

2.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Authors:  S Shimura; G Yang; S Ebara; T M Wheeler; A Frolov; T C Thompson
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

3.  Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Authors:  Marco Erreni; Alberto Mantovani; Paola Allavena
Journal:  Cancer Microenviron       Date:  2010-09-17

4.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

5.  Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas.

Authors:  Hiroshi Nishioka; Jo Haraoka
Journal:  Acta Neuropathol       Date:  2005-05-13       Impact factor: 17.088

6.  Tumor microenvironment and myeloid-derived suppressor cells.

Authors:  Viktor Umansky; Alexandra Sevko
Journal:  Cancer Microenviron       Date:  2012-12-16

7.  Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas.

Authors:  H M Heshmati; M Kujas; S Casanova; P C Wollan; J Racadot; R Van Effenterre; P J Derome; G Turpin
Journal:  Endocr J       Date:  1998-06       Impact factor: 2.349

Review 8.  Prolactin and growth hormone in the regulation of the immune system.

Authors:  R R Gala
Journal:  Proc Soc Exp Biol Med       Date:  1991-10

9.  CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.

Authors:  Smita Kayal; Sandeep Mathur; Asis K Karak; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Vinod Raina
Journal:  Leuk Lymphoma       Date:  2014-03-10

Review 10.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13
View more
  25 in total

Review 1.  Growth hormone in the tumor microenvironment.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Arch Endocrinol Metab       Date:  2019 Nov-Dec       Impact factor: 2.309

2.  The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy.

Authors:  Peng-Fei Wang; Ting-Jian Wang; Ya-Kun Yang; Kun Yao; Zhuo Li; Yan Michael Li; Chang-Xiang Yan
Journal:  J Neurooncol       Date:  2018-04-21       Impact factor: 4.130

Review 3.  Aggressive pituitary tumours and pituitary carcinomas.

Authors:  Gérald Raverot; Mirela Diana Ilie; Hélène Lasolle; Vincent Amodru; Jacqueline Trouillas; Frédéric Castinetti; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2021-09-07       Impact factor: 43.330

4.  The Pituitary Tumors and Their Tumor-Specific Microenvironment.

Authors:  M M Kameda-Smith; J -Q Lu
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  In silico analysis of the immunological landscape of pituitary adenomas.

Authors:  Jacky T Yeung; Matthew D Vesely; Danielle F Miyagishima
Journal:  J Neurooncol       Date:  2020-03-31       Impact factor: 4.130

6.  Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.

Authors:  Yu Mei; Wenya Linda Bi; James Agolia; Changchen Hu; Alexandra M Giantini Larsen; David M Meredith; Sally Al Abdulmohsen; Tejus Bale; Gavin P Dunn; Malak Abedalthagafi; Ian F Dunn
Journal:  Pituitary       Date:  2021-01-25       Impact factor: 4.107

Review 7.  Multifaceted microglia - key players in primary brain tumour heterogeneity.

Authors:  Lily Keane; Mathilde Cheray; Klas Blomgren; Bertrand Joseph
Journal:  Nat Rev Neurol       Date:  2021-03-10       Impact factor: 42.937

Review 8.  Research advances on the immune research and prospect of immunotherapy in pituitary adenomas.

Authors:  Ding Nie; Qiuyue Fang; Bin Li; Jianhua Cheng; Chuzhong Li; Songbai Gui; Yazhuo Zhang; Peng Zhao
Journal:  World J Surg Oncol       Date:  2021-06-05       Impact factor: 2.754

9.  Alterations in CD8+ Tregs, CD56+ Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs).

Authors:  Xinmei Huang; Jiong Xu; Yueyue Wu; Li Sheng; Yue Li; Bingbing Zha; Tiange Sun; Ju Yang; Shufei Zang; Jun Liu
Journal:  Pathol Oncol Res       Date:  2021-03-25       Impact factor: 3.201

Review 10.  Detection of programmed death ligand 1 protein and CD8+ lymphocyte infiltration in plurihormonal pituitary adenomas: A case report and review of the literatures.

Authors:  Pengfei Wang; Tingjian Wang; Yakun Yang; Chunjiang Yu; Ning Liu; Changxiang Yan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.